Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 37 to 43 of 43 entries
Sorted by: Best Match Show Resources per page
Comprehensive biomarker profiling of hypertension in 36 985 Finnish individuals.

Journal of hypertension

Palmu J, Tikkanen E, Havulinna AS, Vartiainen E, Lundqvist A, Ruuskanen MO, Perola M, Ala-Korpela M, Jousilahti P, Würtz P, Salomaa V, Lahti L, Niiranen T.
PMID: 34784307
J Hypertens. 2021 Nov 15; doi: 10.1097/HJH.0000000000003051. Epub 2021 Nov 15.

OBJECTIVE: Previous studies on the association between metabolic biomarkers and hypertension have been limited by small sample sizes, low number of studied biomarkers, and cross-sectional study design. In the largest study to date, we assess the cross-sectional and longitudinal...

Cite
Palmu J, Tikkanen E, Havulinna AS, et al. Comprehensive biomarker profiling of hypertension in 36 985 Finnish individuals. J Hypertens. 2021;doi: 10.1097/HJH.0000000000003051.
Palmu, J., Tikkanen, E., Havulinna, A. S., Vartiainen, E., Lundqvist, A., Ruuskanen, M. O., Perola, M., Ala-Korpela, M., Jousilahti, P., Würtz, P., Salomaa, V., Lahti, L., & Niiranen, T. (2021). Comprehensive biomarker profiling of hypertension in 36 985 Finnish individuals. Journal of hypertension, . https://doi.org/10.1097/HJH.0000000000003051
Palmu, Joonatan, et al. "Comprehensive biomarker profiling of hypertension in 36 985 Finnish individuals." Journal of hypertension vol. (2021). doi: https://doi.org/10.1097/HJH.0000000000003051
Palmu J, Tikkanen E, Havulinna AS, Vartiainen E, Lundqvist A, Ruuskanen MO, Perola M, Ala-Korpela M, Jousilahti P, Würtz P, Salomaa V, Lahti L, Niiranen T. Comprehensive biomarker profiling of hypertension in 36 985 Finnish individuals. J Hypertens. 2021 Nov 15; doi: 10.1097/HJH.0000000000003051. Epub 2021 Nov 15. PMID: 34784307.
Copy Download .nbib Format: NLM
Weight concerns as a predictor of smoking cessation according to nicotine dependence: A population-based study.

Nordisk alkohol- & narkotikatidskrift : NAT

Tuovinen EL, Saarni SE, Kinnunen TH, Ollila H, Ruokolainen O, Patja K, Männistö S, Jousilahti P, Kaprio J, Korhonen T.
PMID: 32934537
Nordisk Alkohol Nark. 2018 Oct;35(5):344-356. doi: 10.1177/1455072518800217. Epub 2018 Sep 20.

BACKGROUND: Nicotine-dependent smokers find it difficult to quit smoking. Additionally, smoking-specific weight concerns may affect smoking cessation although the evidence is controversial. We investigated whether smoking-specific weight concerns predict the probability of cessation and, if so, whether the effect...

Cite
Tuovinen EL, Saarni SE, Kinnunen TH, et al. Weight concerns as a predictor of smoking cessation according to nicotine dependence: A population-based study. Nordisk Alkohol Nark. 2018;35(5):344-356doi: 10.1177/1455072518800217.
Tuovinen, E. L., Saarni, S. E., Kinnunen, T. H., Ollila, H., Ruokolainen, O., Patja, K., Männistö, S., Jousilahti, P., Kaprio, J., & Korhonen, T. (2018). Weight concerns as a predictor of smoking cessation according to nicotine dependence: A population-based study. Nordisk alkohol- & narkotikatidskrift : NAT, 35(5), 344-356. https://doi.org/10.1177/1455072518800217
Tuovinen, Eeva-Liisa, et al. "Weight concerns as a predictor of smoking cessation according to nicotine dependence: A population-based study." Nordisk alkohol- & narkotikatidskrift : NAT vol. 35,5 (2018): 344-356. doi: https://doi.org/10.1177/1455072518800217
Tuovinen EL, Saarni SE, Kinnunen TH, Ollila H, Ruokolainen O, Patja K, Männistö S, Jousilahti P, Kaprio J, Korhonen T. Weight concerns as a predictor of smoking cessation according to nicotine dependence: A population-based study. Nordisk Alkohol Nark. 2018 Oct;35(5):344-356. doi: 10.1177/1455072518800217. Epub 2018 Sep 20. PMID: 32934537; PMCID: PMC7434149.
Copy Download .nbib Format: NLM
Coronary heart disease incidence and mortality, and all-cause mortality among diabetic and non-diabetic people according to their smoking behavior in Finland.

Tobacco induced diseases

Barengo NC, Teuschl Y, Moltchanov V, Laatikainen T, Jousilahti P, Tuomilehto J.
PMID: 28184182
Tob Induc Dis. 2017 Feb 02;15:12. doi: 10.1186/s12971-017-0113-3. eCollection 2017.

BACKGROUND: As type 2 diabetes (T2D) patients have a high risk for coronary heart disease (CHD) and all-cause mortality and smoking is a major single risk factor for total and CHD mortality, it is important to understand the impact...

Cite
Barengo NC, Teuschl Y, Moltchanov V, et al. Coronary heart disease incidence and mortality, and all-cause mortality among diabetic and non-diabetic people according to their smoking behavior in Finland. Tob Induc Dis. 2017;15:12doi: 10.1186/s12971-017-0113-3.
Barengo, N. C., Teuschl, Y., Moltchanov, V., Laatikainen, T., Jousilahti, P., & Tuomilehto, J. (2017). Coronary heart disease incidence and mortality, and all-cause mortality among diabetic and non-diabetic people according to their smoking behavior in Finland. Tobacco induced diseases, 1512. https://doi.org/10.1186/s12971-017-0113-3
Barengo, Noël C, et al. "Coronary heart disease incidence and mortality, and all-cause mortality among diabetic and non-diabetic people according to their smoking behavior in Finland." Tobacco induced diseases vol. 15 (2017): 12. doi: https://doi.org/10.1186/s12971-017-0113-3
Barengo NC, Teuschl Y, Moltchanov V, Laatikainen T, Jousilahti P, Tuomilehto J. Coronary heart disease incidence and mortality, and all-cause mortality among diabetic and non-diabetic people according to their smoking behavior in Finland. Tob Induc Dis. 2017 Feb 02;15:12. doi: 10.1186/s12971-017-0113-3. eCollection 2017. PMID: 28184182; PMCID: PMC5288994.
Copy Download .nbib Format: NLM
The effects of long-term physical activity interventions in communities: Scoping review in the Nordic countries.

Scandinavian journal of public health

Haverinen EH, Elonheimo HM, Tolonen HK, Jousilahti PJ, Wennman HJC.
PMID: 34176347
Scand J Public Health. 2021 Jun 28;14034948211020599. doi: 10.1177/14034948211020599. Epub 2021 Jun 28.

No abstract available.

Cite
Haverinen EH, Elonheimo HM, Tolonen HK, et al. The effects of long-term physical activity interventions in communities: Scoping review in the Nordic countries. Scand J Public Health. 2021;14034948211020599doi: 10.1177/14034948211020599.
Haverinen, E. H., Elonheimo, H. M., Tolonen, H. K., Jousilahti, P. J., & Wennman, H. J. C. (2021). The effects of long-term physical activity interventions in communities: Scoping review in the Nordic countries. Scandinavian journal of public health, 14034948211020599. https://doi.org/10.1177/14034948211020599
Haverinen, Elsi H, et al. "The effects of long-term physical activity interventions in communities: Scoping review in the Nordic countries." Scandinavian journal of public health vol. (2021): 14034948211020599. doi: https://doi.org/10.1177/14034948211020599
Haverinen EH, Elonheimo HM, Tolonen HK, Jousilahti PJ, Wennman HJC. The effects of long-term physical activity interventions in communities: Scoping review in the Nordic countries. Scand J Public Health. 2021 Jun 28;14034948211020599. doi: 10.1177/14034948211020599. Epub 2021 Jun 28. PMID: 34176347.
Copy Download .nbib Format: NLM
Metabolic Biomarker Discovery for Risk of Peripheral Artery Disease Compared With Coronary Artery Disease: Lipoprotein and Metabolite Profiling of 31 657 Individuals From 5 Prospective Cohorts.

Journal of the American Heart Association

Tikkanen E, Jägerroos V, Holmes MV, Sattar N, Ala-Korpela M, Jousilahti P, Lundqvist A, Perola M, Salomaa V, Würtz P.
PMID: 34845932
J Am Heart Assoc. 2021 Dec 07;10(23):e021995. doi: 10.1161/JAHA.121.021995. Epub 2021 Nov 30.

Background Peripheral artery disease (PAD) and coronary artery disease (CAD) represent atherosclerosis in different vascular beds. We used detailed metabolic biomarker profiling to identify common and discordant biomarkers and clarify pathophysiological differences for these vascular diseases. Methods and Results...

Cite
Tikkanen E, Jägerroos V, Holmes MV, et al. Metabolic Biomarker Discovery for Risk of Peripheral Artery Disease Compared With Coronary Artery Disease: Lipoprotein and Metabolite Profiling of 31 657 Individuals From 5 Prospective Cohorts. J Am Heart Assoc. 2021;10(23):e021995doi: 10.1161/JAHA.121.021995.
Tikkanen, E., Jägerroos, V., Holmes, M. V., Sattar, N., Ala-Korpela, M., Jousilahti, P., Lundqvist, A., Perola, M., Salomaa, V., & Würtz, P. (2021). Metabolic Biomarker Discovery for Risk of Peripheral Artery Disease Compared With Coronary Artery Disease: Lipoprotein and Metabolite Profiling of 31 657 Individuals From 5 Prospective Cohorts. Journal of the American Heart Association, 10(23), e021995. https://doi.org/10.1161/JAHA.121.021995
Tikkanen, Emmi, et al. "Metabolic Biomarker Discovery for Risk of Peripheral Artery Disease Compared With Coronary Artery Disease: Lipoprotein and Metabolite Profiling of 31 657 Individuals From 5 Prospective Cohorts." Journal of the American Heart Association vol. 10,23 (2021): e021995. doi: https://doi.org/10.1161/JAHA.121.021995
Tikkanen E, Jägerroos V, Holmes MV, Sattar N, Ala-Korpela M, Jousilahti P, Lundqvist A, Perola M, Salomaa V, Würtz P. Metabolic Biomarker Discovery for Risk of Peripheral Artery Disease Compared With Coronary Artery Disease: Lipoprotein and Metabolite Profiling of 31 657 Individuals From 5 Prospective Cohorts. J Am Heart Assoc. 2021 Dec 07;10(23):e021995. doi: 10.1161/JAHA.121.021995. Epub 2021 Nov 30. PMID: 34845932.
Copy Download .nbib Format: NLM
Metabolic Biomarker Discovery for Risk of Peripheral Artery Disease Compared With Coronary Artery Disease: Lipoprotein and Metabolite Profiling of 31 657 Individuals From 5 Prospective Cohorts.

Journal of the American Heart Association

Tikkanen E, Jägerroos V, Holmes MV, Sattar N, Ala-Korpela M, Jousilahti P, Lundqvist A, Perola M, Salomaa V, Würtz P.
PMID: 34845932
J Am Heart Assoc. 2021 Dec 07;10(23):e021995. doi: 10.1161/JAHA.121.021995. Epub 2021 Nov 30.

Background Peripheral artery disease (PAD) and coronary artery disease (CAD) represent atherosclerosis in different vascular beds. We used detailed metabolic biomarker profiling to identify common and discordant biomarkers and clarify pathophysiological differences for these vascular diseases. Methods and Results...

Cite
Tikkanen E, Jägerroos V, Holmes MV, et al. Metabolic Biomarker Discovery for Risk of Peripheral Artery Disease Compared With Coronary Artery Disease: Lipoprotein and Metabolite Profiling of 31 657 Individuals From 5 Prospective Cohorts. J Am Heart Assoc. 2021;10(23):e021995doi: 10.1161/JAHA.121.021995.
Tikkanen, E., Jägerroos, V., Holmes, M. V., Sattar, N., Ala-Korpela, M., Jousilahti, P., Lundqvist, A., Perola, M., Salomaa, V., & Würtz, P. (2021). Metabolic Biomarker Discovery for Risk of Peripheral Artery Disease Compared With Coronary Artery Disease: Lipoprotein and Metabolite Profiling of 31 657 Individuals From 5 Prospective Cohorts. Journal of the American Heart Association, 10(23), e021995. https://doi.org/10.1161/JAHA.121.021995
Tikkanen, Emmi, et al. "Metabolic Biomarker Discovery for Risk of Peripheral Artery Disease Compared With Coronary Artery Disease: Lipoprotein and Metabolite Profiling of 31 657 Individuals From 5 Prospective Cohorts." Journal of the American Heart Association vol. 10,23 (2021): e021995. doi: https://doi.org/10.1161/JAHA.121.021995
Tikkanen E, Jägerroos V, Holmes MV, Sattar N, Ala-Korpela M, Jousilahti P, Lundqvist A, Perola M, Salomaa V, Würtz P. Metabolic Biomarker Discovery for Risk of Peripheral Artery Disease Compared With Coronary Artery Disease: Lipoprotein and Metabolite Profiling of 31 657 Individuals From 5 Prospective Cohorts. J Am Heart Assoc. 2021 Dec 07;10(23):e021995. doi: 10.1161/JAHA.121.021995. Epub 2021 Nov 30. PMID: 34845932.
Copy Download .nbib Format: NLM
Association of circulating metabolites in plasma or serum and risk of stroke: Meta-analysis from seven prospective cohorts.

Neurology

Vojinovic D, Kalaoja M, Trompet S, Fischer K, Shipley MJ, Li S, Havulinna AS, Perola M, Salomaa V, Yang Q, Sattar N, Jousilahti P, Amin N, Satizabal CL, Taba N, Sabayan B, Vasan RS, Ikram MA, Stott DJ, Ala-Korpela M, Jukema JW, Seshadri S, Kettunen J, Kivimaki M, Esko T, van Duijn CM.
PMID: 33268560
Neurology. 2020 Dec 02; doi: 10.1212/WNL.0000000000011236. Epub 2020 Dec 02.

OBJECTIVE: To conduct a comprehensive analysis of circulating metabolites and incident stroke in large prospective population-based settings.METHODS: We investigated the association of metabolites with risk of stroke in seven prospective cohort studies including 1,791 incident stroke events among 38,797...

Cite
Vojinovic D, Kalaoja M, Trompet S, et al. Association of circulating metabolites in plasma or serum and risk of stroke: Meta-analysis from seven prospective cohorts. Neurology. 2020;doi: 10.1212/WNL.0000000000011236.
Vojinovic, D., Kalaoja, M., Trompet, S., Fischer, K., Shipley, M. J., Li, S., Havulinna, A. S., Perola, M., Salomaa, V., Yang, Q., Sattar, N., Jousilahti, P., Amin, N., Satizabal, C. L., Taba, N., Sabayan, B., Vasan, R. S., Ikram, M. A., Stott, D. J., Ala-Korpela, M., Jukema, J. W., Seshadri, S., Kettunen, J., Kivimaki, M., Esko, T., & van Duijn, C. M. (2020). Association of circulating metabolites in plasma or serum and risk of stroke: Meta-analysis from seven prospective cohorts. Neurology, . https://doi.org/10.1212/WNL.0000000000011236
Vojinovic, Dina, et al. "Association of circulating metabolites in plasma or serum and risk of stroke: Meta-analysis from seven prospective cohorts." Neurology vol. (2020). doi: https://doi.org/10.1212/WNL.0000000000011236
Vojinovic D, Kalaoja M, Trompet S, Fischer K, Shipley MJ, Li S, Havulinna AS, Perola M, Salomaa V, Yang Q, Sattar N, Jousilahti P, Amin N, Satizabal CL, Taba N, Sabayan B, Vasan RS, Ikram MA, Stott DJ, Ala-Korpela M, Jukema JW, Seshadri S, Kettunen J, Kivimaki M, Esko T, van Duijn CM. Association of circulating metabolites in plasma or serum and risk of stroke: Meta-analysis from seven prospective cohorts. Neurology. 2020 Dec 02; doi: 10.1212/WNL.0000000000011236. Epub 2020 Dec 02. PMID: 33268560; PMCID: PMC8055347.
Copy Download .nbib Format: NLM
Showing 37 to 43 of 43 entries